Bell Biosystems

About:

Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.

Website: http://bellbiosystems.com

Twitter/X: BellBiosystems

Top Investors: Band of Angels, TSVC, LiteCap

Description:

Bell Biosystems is a biotechnology company based in Berkeley, CA, and focused on developing tools for the tracking and imaging of cellular therapies. Bell combines expertise in stem cell research, cell biology, biomedical imaging, molecular biology and clinical regenerative medicine. Our vision is to create tools that accelerate the "bench-to-bedside" progress of innovations in cell therapy pre-clinical and clinical delivery and tracking of transplanted cells.

Total Funding Amount:

$8.31M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)bellbiosystems.com

Founders:

Caleb Bell

Number of Employees:

1-10

Last Funding Date:

2015-04-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai